共 50 条
- [22] Does prostate-specific antigen (PSA) mass or free PSA mass improve the accuracy of predicting total prostate volume in relation to obesity in men with biopsy-proven benign prostatic hyperplasia? ASIAN JOURNAL OF ANDROLOGY, 2019, 21 (01): : 86 - 91
- [24] Prostate specific antigen volatility index (PVI) discriminates men with prostate cancer from those with biopsy-proven benign prostatic hyperplasia (BPH) JOURNAL OF UROLOGY, 2008, 179 (04): : 573 - 573
- [27] RELATIVE RISK OF POSITIVE PROSTATE BIOPSY VS. PROSTATE CANCER MORTALITY BY PSA LEVEL AT AGE 60 JOURNAL OF UROLOGY, 2013, 189 (04): : E845 - E845
- [28] Prostate Specific Antigen Velocity Risk Count Predicts Biopsy Reclassification for Men with Very Low Risk Prostate Cancer JOURNAL OF UROLOGY, 2014, 191 (03): : 629 - 637